This Ministerial Ordinance is intended to provide the standards, which serve as the GCP for Drugs, specified by the Minister of Health, Labour and Welfare pursuant of the Pharmaceutical Affairs Act and the standards specified by MHLW Ordinance pursuant to as to ensure the scientific quality of clinical trials and the reliability of clinical trial data while the rights, safety and welfare of human subjects are protected and promoted.